A

Abcam

2330 employees

Abcam helps researches with breakthroughs in areas such as cancer, neurological disorders, infectious diseases, and metabolic disorders.

Investor insights

Sectors invested in

Biopharma1
Medical1
Biotechnology1

Funding rounds participated in

$2.9M sweet spot round size

Most of their 1 investments are in rounds between $2.9M and $2.9M

Basic info

Industry

biotechnology research

Sectors

Biotechnology
biological reagents
Life Science
RabMAb
research
rabbit antibodies
gene-edited cell lines
drug discovery
monoclonal antibodies
Life Sciences
knockout cell lines
immunoassays
custom services
diagnostics
proteins
antibodies

Date founded

1998

Investments made

S

Somaserve raised $2.9M on April 20, 2021

Investors: Meltwind Advisory LLP, Origin Capital, o2h ventures and Abcam

FAQ